Maternal respiratory syncytial virus antibody titers: Season and children matter

Pediatric Infectious Disease Journal

Volumn 22, Issue 6, 2003, Pages 563-564

  Le Saux, Nicole ^a   Gaboury, Isabelle ^a   MacDonald, Noni ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antibody titers; Fusion glycoprotein; Maternal sera; Respiratory syncytial virus

Indexed keywords

IMMUNOGLOBULIN G1; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; DELIVERY; FEMALE; HUMAN; INFECTION RESISTANCE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SEASONAL VARIATION;

EID: 0037863886     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000069796.72540.0a     Document Type: Article

References (12)

1. Englund JA. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatr Infect Dis J 1994;13:449-53.
2. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981;98:708-15.
3. Lamprecht CL, Krause HE, Mufson MA. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis 1976;134:211-17.
4. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-6.
5. Munoz FM, Piedra PA, Maccato M, Kozinetz C, Glezen WP. Safety and immunogenicity of respiratory syncytial virus (RSV) purified fusion protein-2 (PFP-2) vaccine in pregnant women [Abstract 6]. In: 39th Annual Meeting of the Infectious Diseases Society of America, San Francisco, October 25 to 28, 2001. Alexandria, VA: Infectious Diseases Society of America, 2001:40.
6. Murphy BR, Graham BS, Prince GA, et al. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol 1986;23:1009-14.
7. Karron RA, Singleton RJ, Bulkow L, et al. Severe respiratory syncytial virus disease in Alaska native children: RSV Alaska Study Group. J Infect Dis 1999;180:41-9.
8. Nandapalan N, Taylor CE, Greenwell J, et al. Seasonal variations in maternal serum and mammary immunity to RS virus. J Med Virol 1986;20:79-87.
9. de Sierra TM, Kumar ML, Wasser TE, Murphy BR, Subbarao EK. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993;122:787-91.
10. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991;163:693-8.
11. Hall CB, Geiman JM, Biggar R, Kotok DI, Hogan PM, Douglas GR, Jr. Respiratory syncytial virus infections within families. N Engl J Med 1976;294:414-9.
12. Hall CB, Long CE, Schnabel KC. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 2001;33:792-6.